uniQure (QURE) Receivables - Other (2015 - 2023)
uniQure (QURE) posted quarterly Receivables - Other of $100.0 million for Q1 2023, up 81.82% year-over-year from $55.0 million in Q1 2022, and little changed quarter-over-quarter from $100.0 million in Q4 2022.
Analysis
uniQure (QURE) Receivables - Other (2015 - 2023) Analysis & Trends
uniQure's Receivables - Other history runs 9 years deep, the most recent figure standing at $100.0 million for Q1 2023.
- In Q1 2023, Receivables - Other rose 81.82% year-over-year to $100.0 million; the TTM figure through Mar 2023 stood at $100.0 million (up 81.82% YoY), while the FY2022 annual figure was $100.0 million, up 81.82% from the prior year.
- Receivables - Other for Q1 2023 stood at $100.0 million, roughly flat from $100.0 million in the prior quarter.
- The five-year high for Receivables - Other was $100.0 million in Q4 2022, with the low at $101000.0 in Q3 2019.
- The 5-year median for Receivables - Other is $947000.0 (2019), against an average of $28.6 million.
- The sharpest annual moves came in 2019 and 2021: Receivables - Other plunged 81.7% in 2019, then surged 1112.52% in 2021.
- uniQure's Receivables - Other stood at $947000.0 in 2019, then soared by 378.99% to $4.5 million in 2020, then soared by 1112.52% to $55.0 million in 2021, then jumped by 81.82% to $100.0 million in 2022, then changed by 0.0% to $100.0 million in 2023.
- Business Quant data shows QURE's Receivables - Other at $100.0 million in Q1 2023, $100.0 million in Q4 2022, and $55.0 million in Q2 2022.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 138.47 Bn | 130.62 Bn | 2.84 Bn |
| 2 | Regeneron Pharmaceuticals | 85.18 Bn | 77.19 Bn | 3.93 Bn |
| 3 | Argenx Se | 63.38 Bn | 58.19 Bn | 1.37 Bn |
| 4 | Moderna | 58.09 Bn | 52.95 Bn | 52.00 Mn |
| 5 | Revolution Medicines | 44.33 Bn | 44.33 Bn | - |
| 6 | BeOne Medicines | 40.02 Bn | 34.92 Bn | 1.53 Bn |
| 7 | Alnylam Pharmaceuticals | 35.57 Bn | 32.27 Bn | 992.69 Mn |
| 8 | Royalty Pharma | 28.45 Bn | 27.61 Bn | - |
| 9 | Insmed | 27.48 Bn | 26.32 Bn | 358.27 Mn |
| 10 | uniQure | 2.95 Bn | 2.95 Bn | 5.49 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Mar 31, 2023 | 100.00 Mn |
| Dec 31, 2022 | 100.00 Mn |
| Jun 30, 2022 | 55.00 Mn |
| Mar 31, 2022 | 55.00 Mn |
| Dec 31, 2021 | 55.00 Mn |
| Dec 31, 2020 | 4.54 Mn |
| Sep 30, 2020 | 223,000.00 |
| Jun 30, 2020 | 222,000.00 |
| Mar 31, 2020 | 258,000.00 |
| Dec 31, 2019 | 947,000.00 |
| Sep 30, 2019 | 101,000.00 |
| Jun 30, 2019 | 355,000.00 |
| Mar 31, 2019 | 461,000.00 |
| Dec 31, 2018 | 233,000.00 |
| Sep 30, 2018 | 552,000.00 |
| Jun 30, 2018 | 1.04 Mn |
| Mar 31, 2018 | 1.06 Mn |
| Dec 31, 2017 | 1.59 Mn |
| Sep 30, 2017 | 1.95 Mn |
| Jun 30, 2017 | 1.63 Mn |